Welcome to the Drug Hypersensitivity Symposium 2026 – Challenging Evidence, a meeting that brings together the world’s leading science, new discoveries, and the latest evidence to drive meaningful change in clinical drug allergy practice.

Welcome to the Drug Hypersensitivity Symposium 2026 – Challenging Evidence, a meeting that brings together the world’s leading science, new discoveries, and the latest evidence to drive meaningful cha...

Abstracts Important Dates Abstract submission closes: 31 July 2026, 11:59 PM (AEST) Abstract Submission Guidelines Eligibility Abstracts must be submitted by the presenting author or a nominated co-a...

Welcome to the Drug Hypersensitivity Symposium 2026 – Challenging Evidence, a meeting that brings together the world’s leading science, new discoveries, and the latest evidence to drive meaningful cha...

Welcome to the Drug Hypersensitivity Symposium 2026 – Challenging Evidence, a meeting that brings together the world’s leading science, new discoveries, and the latest evidence to drive meaningful cha...

Welcome to the Drug Hypersensitivity Symposium 2026 – Challenging Evidence, a meeting that brings together the world’s leading science, new discoveries, and the latest evidence to drive meaningful cha...

We aimed to evaluate the feasibility of conducting a multicenter, double-blind, placebo-controlled trial of prolonged (i.e., multidose) compared with single-dose amoxicillin challenge in patients w...

We aimed to evaluate the feasibility of conducting a multicenter, double-blind, placebo-controlled trial of prolonged (i.e., multidose) compared with single-dose amoxicillin challenge in patients w...

This pilot randomized clinical trial assesses the feasibility and safety of using a smartphone application for antibiotic allergy assessment and delabeling in anesthesiologist-led clinics among patien...

Patients labelled with penicillin allergy (PenA) often receive broader spectrum antibiotics, associated with antimicrobial resistance and poorer outco…

In this trial involving patients with hematologic cancers, the immune responses that were elicited were similar for adjuvanted-dose and standard-dose influenza vaccines.

Inpatient penicillin allergy is associated with inappropriate antibiotic prescribing and adverse patient outcomes. We reviewed the long-term effectiveness, safety and antimicrobial stewardship impacts of a pharmacist-led penicillin allergy delabelling ward round.

Inpatient penicillin allergy is associated with inappropriate antibiotic prescribing and adverse patient outcomes. We reviewed the long-term effective…

Our findings propose a causal relationship between reduced IL-6 signalling and lower risk of tuberculosis, akin to the effect seen in other IL-6 mediated diseases. This study suggests that IL-6 antago...

Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom ...

Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. In a multicenter, non...

Penicillin allergy is a significant burden on patient, prescribing and hospital outcomes. There has been increasing interest in the incorporation of penicillin allergy testing (i.e. delabelling) into ...

Unusual exchange the other day with one of my (non-ID) colleagues. All dialogue reported verbatim: Non-ID guy: Hi Paul. Me:  Hi Jon. [I’m expecting the next line to be: “Quick question: I’ve got a pat...

Objective.  —To establish (1) the prevalence of positive penicillin skin tests among outpatients with well-defined but variable history of penicillin allergy and (2) the reproducibility, safety, a...